The October 2020 FREIA newsletter is released today. We are proud to share some of our research updates, recently published papers, future activities, and introduce you to our talented researcher Hanna Johansson.
Despite the covid-19 pandemic, the FREIA team has done a great job to continue working towards the FREIA goal: provide better test methods for identification of EDCs harmful for female reproductive health.
The FREIA consortium met on 29-30 October 2019 to share updates on the work progress. All partners were represented by one or more researchers at the meeting that was hosted by VU Amsterdam.
The first results from the laboratory experiments and computational modelling were presented to the partners. There was some exchange of views on which EDCs should be measured in the human samples that are available within FREIA.
Coordinator Majorie van Duursen: “it was so great to see the enthusiasm and dedication of this wonderful group. We are well on schedule with the planned work”.
Besides the experimental work, the FREIA consortium is working on a review paper to describe how EDCs cause female reproductive health issues. The paper is expected to be published early 2020. Future activities to communicate FREIA goals were also on the agenda. Many great ideas were formed on newsletters and webinars.
All in all, it was a very productive meeting with great promise to achieve FREIA goals.
JANUARY 28, 2019 | The FREIA project has started with a kick-off meeting in Hotel Zuiderduin (Egmond aan Zee, The Netherlands) on 28 and 29 January 2019. The sister projects ATHENA, ENDpoiNTs, and GOLIATH were having their kick-off meeting at the same venue. The official EU launch was held adjacently in Brussels on 31 January.